To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Clinical trial NCT05968768 · RECRUITING
Trial details
- NCT number
- NCT05968768
- Sponsor
- Anna Raciborska
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2027-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.